Lilly Yue

Lilly Qinli Yue is a US government statististician, known for her work on "real-world evidence" on health care from non-clinical sources such as billing data and product registries.^[1] She is deputy director of the Division of Biostatistics in the Center for Devices and Radiological Health of the Food and Drug Administration.^[2]

Education and career

Yue has a bachelor's degree in mathematics, a master's degree in stochastic operations research, and a master's degree in mathematical statistics.^[2][3] She completed a Ph.D. at Texas A&M University in 1996, with the dissertation Chemometric Calibration and Partial Least Squares supervised by Michael Longnecker.^[4]

She was a senior statistician at Eli Lilly and Company before moving to the Food and Drug Administration in 1998.^[3]

Recognition

Yue was elected as a Fellow of the American Statistical Association in 2014.^[5] In 2020, as part of the RWE Methods Group at the FDA, she was a recipient of the FDA's Excellence in Data Science Group Award, "for extraordinary achievements in the timely development and active promotion of novel statistical methods for leveraging real-world evidence to support regulatory decision-making".^[6]